alexa Advanced 3D Vascularized In Vitro Models Of Human Bone And Muscle To Study Tumor Cell Extravasation
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

8th International Conference on Tissue Science and Regenerative Medicine
September 11- 12, 2017 Singapore

Matteo Moretti, Bersini S, Arrigoni C, Gilardi M, Talo G, Lopa S, Bongio M, Vanoni M Dubini G and Kamm R D
IRCCS Istituto Ortopedico Galeazzi, Italy
Università Milano-Bicocca, Italy
Politecnico di Milano, Italy
Massachusetts Institute of Technology, USA
ScientificTracks Abstracts: J Tissue Sci Eng
DOI: 10.4172/2157-7552-C1-036
Abstract
Cancer metastases cause 90% of cancer deaths and affect different organs, depending on the tumor, e.g., breast cancer metastasizes to bone but not to skeletal muscle. Extravasation is the last critical step of metastatic cascade before organ colonization and for its investigation; standard in vitro models are oversimplified, while in vivo models are analytically limited and present species-specific differences in pathological mechanisms. Thus, we generated innovative in vitro models for the study of breast cancer cell (BCC) extravasation. Our models are based on 3D gels embedding co-cultures of human bone, muscle and vascular cells. They can be either microscale based on microfluidics or mesoscale, exploiting ad-hoc designed supports. BCCs injected into microvascular networks of our models extravasated more towards bone model, compared to control and to skeletal muscle model (56.5±4.8% vs. 14.7±3.6% vs. 8.2±2.3%) although permeability of the bone endothelium was lower. Furthermore, adenosine addition to the bone model decreased extravasation (12.7±2.8% vs. 56.5±4.8%) and the supplementation of a specific adenosine inhibitor in the muscle model increased BCC extravasation (32.4±7.7% vs. 8.2±2.3%). Furthermore, with these models we demonstrated the key role of Talin-1 protein in the extravasation process. We also generated the first 3D in vitro mesoscale models of metabolically active human bone and we have biofabricated a 3D human vascularized skeletal muscle environment, which not only incorporates a physiological muscle-specific vascular network, but also includes muscle-supporting fibroblasts recapitulating the structure of the endomysium. In conclusion, our 3D in vitro human models, vascularized and organ-specific allowed us to replicate the process of extravasation of breast cancer cells and to investigate its basic biological mechanisms, thanks to the control on the microenvironment and to the high resolution of analytical methods.
Biography

Matteo Moretti is the Director of the Cell and Tissue Engineering Lab at Galeazzi Hospital in Milan, Italy and of the Regenerative Medicine Technologies Lab at EOC in Lugano, Switzerland. His main research interests lie within micro and meso-scale advanced cell culture technologies. He has developed multiscale bioreactor systems from design to fully working prototypes, aimed at up-scalable, automated platforms as a key to more viable advanced therapies. Furthermore, he has worked on the application of different physicochemical cues to engineered vascularized physiological and pathological tissues, with concern to human primary in vitro 3D model systems aimed at translational applications and as novel tools for biology research. He is a Treasurer of the Tissue Engineering and Regenerative Medicine Society European chapter (TERMIS-EU). He has authored more than 60 papers on international peer-reviewed journals and has co-founded two biotech start-ups.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords